| Groups | Nanodrug concentrations (micrograms per milliliter) | Serum cholesterol level (mg/dl) |
| Intraperitoneal nanodrug receiver | 20 | 198 |
| 40 | 187 | |
| 60 | 156 | |
| Injector nanodrug receiver | 20 | 207 |
| 40 | 143 | |
| 60 | 140 | |
| Oral nanodrug receiver | 20 | 201 |
| 40 | 99 | |
| 60 | 102 | |
| Control |
| 582 |